Physician profile
Peter R Fried
NPI 1851384671
$44,556.11
in general payments reported to CMS, 2019-2025
32 companies · $909 in 2025
The $909 reported for 2025 was more than what 82% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $396 · 2021: $368 · 2022: $6,427 · 2023: $19K · 2024: $17K · 2025: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $5,477 · Food and Beverage: $3,943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,300.00 |
| Travel and Lodging | $5,477.30 |
| Food and Beverage | $3,943.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $37,190.59 | 2022-2025 | Pylarify |
| Siemens Medical Solutions USA, INC. | $1,914.20 | 2024 | Varian Ethos Treatment Planning |
| Janssen Scientific Affairs, LLC | $674.04 | 2019-2025 | Erleada, Akeega, Pipeline |
| Novartis Pharmaceuticals Corporation | $538.86 | 2022-2025 | |
| Elekta, INC. | $511.85 | 2019-2022 | |
| Teleflex LLC | $457.57 | 2024-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $445.39 | 2022-2024 | Spaceoar Vue System - 10ml, Spaceoar System |
| Bayer Healthcare Pharmaceuticals INC. | $414.11 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $329.24 | 2019-2025 | Provenge |
| Myovant Sciences INC. | $286.93 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $220.03 | 2023-2025 | Lynparza |
| Palette Life Sciences, INC. | $180.00 | 2022 | |
| Axonics, INC. | $157.64 | 2020-2023 | Axonics |
| Astellas Pharma US INC | $153.80 | 2019-2024 | Xtandi |
| Merck Sharp & Dohme LLC | $123.84 | 2023 | Lynparza |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clovis Oncology, INC. | $120.70 | 2019 | |
| Myriad Genetic Laboratories, INC. | $108.77 | 2023 | Prolaris |
| Tempus Ai, INC | $98.42 | 2024 | |
| Blue Earth Diagnostics | $93.35 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $83.27 | 2023-2025 | Orgovyx |
| Foundation Medicine, INC. | $80.00 | 2022 | |
| Janssen Biotech, INC. | $79.55 | 2019-2025 | Erleada |
| Bard Peripheral Vascular, INC. | $49.14 | 2023-2025 | Model 200 Theraseed Palladium-103 In Readylink |
| Incyte Corporation | $47.10 | 2024-2025 | Monjuvi, Pemazyre, Zynyz |
| Pfizer INC. | $42.57 | 2022-2025 | |
| Abbvie INC. | $34.09 | 2025 | |
| Telix Pharmaceuticals | $27.06 | 2024 | Illuccix |
| Isoray, INC | $21.73 | 2024 | Brachytherapy Source |
| Immunitybio, INC. | $20.82 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $19.68 | 2020 | |
| Stemline Therapeutics INC. | $16.78 | 2024 | Orserdu |
| Tersera Therapeutics LLC | $14.99 | 2025 | Zoladex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Fried listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.